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Transmissible spongiform encephalopathies (TSes) or prion 
diseases, are neurological diseases that can be transmitted 
through a number of different routes. A wide range of 
mammalian species are affected by the disease. After peripheral 
exposure, some TSe agents accumulate in lymphoid tissues at 
an early stage of disease prior to spreading to the nerves and the 
brain. Much research has focused on identifying the cells and 
molecules involved in the transmission of TSe agents from the 
site of exposure to the brain and several crucial cell types have 
been associated with this process. The identification of the key 
cells that influence the different stages of disease transmission 
might identify targets for therapeutic intervention. This review 
highlights the involvement of mononuclear phagocytes in TSe 
disease. Current data suggest these cells may exhibit a diverse 
range of roles in TSe disease from the transport or destruction 
of TSe agents in lymphoid tissues, to mediators or protectors of 
neuropathology in the brain.
genotype (which encodes the cellular prion protein PrPC) of the 
animal can significantly influence disease pathogenesis.3,4 Other 
forms of the disease, such as bovine spongiform encephalopathy 
(BSE), appear not to be associated with early TSE agent replica-
tion in the peripheral lymphoid tissue of cattle,5 but PrPSc and/
or infectivity have been detected in the gut of experimentally 
and naturally infected cattle.6-10 This difference between TSE 
agent strain targeting in host tissues is interesting since when 
BSE transmitted to other species, agent accumulation in the 
lymphoid tissues is a key feature of variant Creutzfeldt-Jakob 
disease in humans.11,12
The replication of TSE agents by host cells is critically depen-
dent upon the expression of the host encoded, cellular isoform of 
the prion protein, PrPC.13 PrPC is an endogenous protein which is 
expressed on a large range of different cell types throughout the 
body.14-19 The normal cellular form of PrP has a mainly α-helical 
structure20 and is protease sensitive. PrPC is a 30–35 kDa gly-
coprotein which is anchored to the outer layer of the cell mem-
brane through a glycosylphosphatidylinositol (GPI) anchor.21 
Although early studies determined that PrPC deficient mice do 
not appear to be adversely affected by the absence of the pro-
tein,22 are not wholly immunodeficient,23 and are developmen-
tally normal,24 recent studies using PrP-deficient mice show, that 
PrPC is associated with suppression of cognitive function caused 
by brain-derived amyloid-β in Alzheimer disease,25 as well as 
blocking pain receptors.26 The protein’s protective function is 
also associated with epilepsy,27,28 and Martins et al. present the 
view that as well as playing a role in “loss-of-function compo-
nents” in prion diseases, PrPC might also be a component in 
the pathogenesis of other neurodegenerative diseases.28 In addi-
tion there has been some speculation about its function in the 
immune system, for example in mediating pro-survival signals in 
cells in certain circumstances such as rapid memory cell expan-
sion,23 and a potential role in T lymphocyte activation.15,29,30
TSE diseases are characteristically associated with the accu-
mulation of insoluble aggregates of the disease-specific abnor-
mal form of PrP within the CNS and, in some cases, within the 
lymphoreticular system (LRS). This abnormal form of the pro-
tein is a relatively protease resistant, predominantly β-pleated 
sheet isoform, termed PrPSc.20 Both PrPC and PrPSc are associ-
ated with three different isoforms that are glycosylated at zero, 
Transmissible Spongiform Encephalopathies (TSEs)
The TSEs are a group of fatal neurodegenerative diseases that 
affect both humans and animals. These diseases can occur 
under several different forms: spontaneous, genetic or acquired 
through various routes of exposure. Examples of the main dis-
ease forms and the species they affect are listed in Table 1. TSE 
disease is characteristically associated with vacuolation in the 
brain (spongiform pathology), neuronal loss, glial cell activation 
and amyloid deposits of the disease-associated form of prion 
protein (PrP), which eventually lead to neurodegeneration and 
death.
Despite being a neurodegenerative disease, natural transmis-
sion often occurs in the periphery before spreading to the cen-
tral nervous system (CNS). Indeed, in some experimental and 
natural TSEs, such as natural sheep scrapie, disease is charac-
terized by early agent accumulation in the peripheral lymphoid 
system.1,2 However, it is worth noting that even within a single 
species such as the sheep, the strain of the TSE agent or PRNP 
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is impaired and disease susceptibility reduced. FDCs are con-
sidered to amplify TSE agents above the threshold required for 
neuroinvasion.
Table 1. TSe diseases
TSE disease Affected species Route of transmission
iatrogenic Creutzfeldt-Jacob disease Human Accidental medical exposure to CJD-contaminated tissues or tissue products
Sporadic Creutzfeldt-Jacob disease (sCJD) Human Unknown. Somatic mutation ro spontaneous conversion of PrPc to PrPSc?
variant Creutzfeldt-Jacob disease (vCJD) Human
ingestion of BSe-contaminated food or blood transfusion from CJD-infected 
blood donor
Familial Creutzfeldt-Jacob disease Human Germline mutations of the PRNP gene
Gerstmann-Straussler-Scheinker syndrome Human Germline mutations of the PRNP gene
Kuru Human ritualistic cannibalism
Fatal familial insomnia Human Germline mutations of the PRNP gene
Bovine Spongiform encephalopathy Cattle ingest ion of contaminated feed
Scrapie Sheep, goats Acquired, ingestion, horizontal transmission, vertical transmission unclear
Chronice wasting disease elk, deer, moose Acquired, ingestion, horizontal transmission, vertical transmission unclear
Transmissible mink encephalopathy Mink Acquired (ingestion) source unknown
Feline spongiform encephalopathy
Domestic and 
zoological cats
ingestion of BSe-contaminated food
exotic ungulate encephalopathy Nyala, Kudu ingestion of BSe-contaminated food
Figure 1. PrPC is strongly expressed on FDCs in the lymphoid follicles of 
the spleen. images taken from mouse spleen immunolabelled with the 
anti-CD45r [green, (A)], anti-PrP (1B3) [blue, (B)] and anti-CD35 [red, (C)] 
antibodies. FDCs and CD35-expressing B cells detected with the anti-
CD35 specific antibody. B cells detected with the anti-CD45r specific 
antibody and PrPC expression was detected using the 1B3 polyclonal 
antibody.126 (D) merged image of all three antibodies.
one or both of the protein’s two possible glycosylation sites, situ-
ated at residues 181 and 197 of human PrP, and residues 180 
and 196 in murine PrP.31 According to the “prion hypothesis,”32 
PrPSc is the infectious agent in TSE disease and it is this protein 
that causes PrPc to convert to the disease associated isoform. 
Quaking-induced conversion (QUIC),33 and protein misfold-
ing cyclic amplification (PMCA),34 are methods which allow 
for the amplification of protein, in a similar manner to DNA 
amplification by polymerase chain reaction (PCR).35 These 
techniques have enabled propagation of infectious PrP using 
infected brain-derived or recombinant PrP. As well as studying 
PrP conversion, these techniques have enabled the detection of 
infectious TSE agents in various tissues at dilutions previously 
undetected by other methods. This had only been performed 
in the presence of additional cofactors such as nucleic acids and 
lipids, but recently, infectious prions were generated by PMCA 
from recombinant hamster prion protein without any apparent 
cofactors.36 Data derived from the use of these two techniques 
lend further weight to the argument of a protein hypothesis in 
disease transmission.36
An important question that still surrounds these diseases 
is how the TSE agent is transported from the site of infection 
to the LRS and onwards into the CNS. Much speculation has 
surrounded the issue of whether the TSE agent is transported 
via cell-associated or cell-free mechanisms. Studies in cer-
tain species show that when LRS involvement occurs during 
the early stages of TSE infection, PrPSc accumulates first on 
PrPC-expressing follicular dendritic cells (FDCs).4,37-41 FDCs 
are stromal-derived, tissue resident cells, found in the ger-
minal centers of lymphoid follicles.42 These cells express high 
levels of PrPC on their surface (Fig. 1), and are clearly associ-
ated with PrPSc accumulation in peripheral lymphoid tissues 
(Fig. 2). The FDC has since been identified as an important 
site of TSE agent accumulation and replication in the LRS.19,43-45   
Furthermore, in the absence of FDCs, TSE agent neuroinvasion © 2012 Landes Bioscience.
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The precise ontogeny of classical DCs and macrophages is the 
subject of much debate. Indeed, there is growing evidence that 
these two cells types are not as distinct from each other as was 
once thought.46-48 These cells are often identified or isolated based 
solely on the expression of a small set of cell surface markers, 
such as CD11c/Itgax for DCs,49 and CD207/langerin for LCs.50-
53 Even under the traditional “umbrella terms” of DCs and mac-
rophages more distinct cellular subsets have been described based 
on the expression of a long list of different markers. However, 
the expression of these and other markers has been shown to be 
less specific than was originally considered.46,54 For example, the 
temporary depletion of CD11c+ cells in CD11c-DTR transgenic 
mice, originally considered to specifically deplete DCs,55 has 
been shown to also deplete many other macrophage subsets, such 
as the CD169+ macrophages in the spleen and lymph nodes (LN) 
(Fig. 3).46,54 Much of the data described in this review was gen-
erated from in vitro experiments utilizing bone marrow-derived 
DCs. However, the recent meta-analysis of a large collection of 
gene expression data from a range of mouse leukocyte lineages 
shows bone marrow-DCs were clearly identified as phagocytes 
(macrophages) and were transcriptionally distinct from tissue 
classical DCs. Indeed, there are few mRNA markers that clearly 
distinguish classical DCs from macrophages other than low 
expression of those required for phagocytosis.48 Clearly, without 
also testing their biological properties (phagocytosis, ability to 
stimulate naïve T cells, etc.) it is difficult to accurately distin-
guish between classical DCs and macrophages based solely on 
the expression of a limited set of surfaces markers. This is espe-
cially true in immunohistochemistry-based studies. While the 
authors considered it important to highlight the ambiguity sur-
rounding the discrimination of individual MNP populations, we 
stick to the traditional terms of macrophages or DCs within this 
review to avoid further confusion!
Classical DCs: Taxis for TSE Agents?
Haematopoietic, classical DCs are a distinct cell type from 
mesenchymal-derived FDCs.42 Classical DCs are antigen pre-
senting cells (APCs) and as such they sample their natural envi-
ronment for foreign antigens, which they process and transport 
to the nearest lymphoid tissues to initiate a specific immune 
response. Classical DCs take up antigen through endocytosis or 
sometimes macropinocytosis.56 Classical DCs travel via the lym-
phatic system to the secondary lymphoid organs in response to 
chemokine stimulation where they present antigen to lympho-
cytes.57 Although the primary role of DCs is to present antigens 
to T cells, they are also capable of presenting them to B cells. 
This sometimes occurs in the form of intact antigen, in contrast 
to the processed antigen presented to T cells.58 These characteris-
tics therefore identify classical DCs as possible candidates for the 
transport of the intact TSE agents from the site of exposure to 
the peripheral lymphoid system. Indeed, studies show the reten-
tion of PrPSc within bone marrow derived DCs 72 h after in vitro 
exposure to PrPSc-enriched scrapie associated fibrils.59 However, 
another study has also suggested that bone marrow-derived DCs 
rapidly degrade PrPSc,60,61 but as we described above, these cells 
Mononuclear Phagocytes (MNPs)  
and TSE Pathogenesis
Even though peripheral lymphoid tissues, and the FDCs within 
them, have been identified as important sites of TSE agent repli-
cation prior to neuroinvasion, little is known of how TSE agents 
are transported to these sites or what, if any, cells are involved. 
MNPs are a diverse group of hematopoietically-derived phago-
cytic cells which includes classical dendritic cells (DCs) and mac-
rophages, but also Langerhans cells (LCs) in the epidermis of the 
skin and microglia in the brain. The distribution of these cells 
at the body’s surfaces (intestine, skin, mucosa, etc.,) and their 
ability to phagocytose antigens and deliver them to draining lym-
phoid tissues, suggested MNPs may either destroy TSE agents or 
transport them within the host.
Figure 2. PrPSc accumulates in the draining LN following scrapie infec-
tion via the skin. (A) PrPd was detected with the anti-PrP specific anti-
body 6H4 in the draining inguinal LN five weeks post scrapie infection. 
(B) Paraffin embedded tissue (PeT) blot analysis of adjacent sections 
confirms PrPd accumulations to be proteinase K resistant PrPSc. (C) en-
larged image of PrPd labeling from boxed area of (A). (D) shows location 
of FDCs via immostaining with the anti-CD21/CD35 specific antibody. 
PrPSc is accumulating on FDCs in the LNs.© 2012 Landes Bioscience.
Do not distribute.
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Skin and Musosa
TSE agents can be readily transmitted via lesions to the skin67-70 
and oral mucosa.71-73 Thus, natural TSE infections might also 
occur via lesions in the mouth and gastrointestinal tract through 
consumption of rough feed or birth-associated lesions to the skin 
or mucus membranes. Furthermore, TSE agent infectivity has 
also been identified in the skin,74-76 as well as in antler velvet.77
The skin provides a first line of defense against infection and 
is therefore the primary site of residence for a number of MNPs 
that help to maintain this barrier. These MNPs include LCs in 
the epidermis and classical dendritic cells and macrophages in 
are highly phagocytic when compared with classical DC from 
tissues.
Classical DCs could influence TSE pathogenesis at a variety of 
stages in the disease process: transport from the site of infection 
to the LRS in the case of LRS involvement; transport between 
cells within the lymphoid tissues; or the transfer between the 
lymphoid tissues and the nervous system (neuroinvasion). The 
argument for a DC-related role in TSE pathogenesis is strength-
ened by the evidence that the prion protein fragment 106–126 
functions as a chemoattractant to immature monocyte-derived 
DCs.62 Evidence for a possible role of DCs in the delivery of TSE 
agents to lymphoid tissues was provided by using a transgenic 
mouse model in which CD11c+ cells63 or CD8+CD11c+ 64 cells 
were significantly reduced. The absence of these cells at the time 
of intraperitoneal scrapie infection significantly prolonged the 
incubation period of the disease when compared with wild type 
controls.63,64
DCs in the Gut
The oral route is considered a major route of exposure for many 
naturally acquired TSEs such as natural sheep scrapie, BSE, 
chronic wasting disease in cervids and variant CJD 
(vCJD) in man. Studies of experimental transmis-
sions in mice and sheep naturally affected with scrapie 
show TSE agents accumulate first in the gut-associated 
lymphoid tissue (GALT) such as the Peyer’s patches 
and mesenteric LN.4 The accumulation of TSE agents 
upon FDCs within the GALT is crucial for the effi-
cient spread of disease to the brain.37,40 Studies have 
also investigated the role of DCs in the transport of the 
TSE agent from the intestinal lumen to the GALT.59,65 
Huang et al.59 used thoracic duct canulation to col-
lect the cells and lymph draining the intestines of rats 
intra-intestinally injected with PrPSc. Data from this 
study showed that intestinal DCs could acquire and 
transport PrPSc from the intestinal lumen, to the mes-
enteric LN, via the lymph, within hours of intestinal 
exposure. Furthermore, using CD11c-DTR trans-
genic mice in which CD11c+ cells can be specifically 
depleted,55 it was shown that an absence of CD11c+ 
cells at the time of oral infection blocked the early 
TSE agent accumulation in the GALT and spleen. 
Additionally, the overall susceptibility to scrapie dis-
ease was reduced in mice where the CD11c+ cells were 
depleted prior to scrapie challenge. These data imply that CD11c+ 
cells play a crucial role in the transport of the scrapie agent from 
the intestinal lumen to the GALT. Whether these data indicate a 
role for classical DCs or macrophages remains to be determined, 
since recent analysis of the CD11c-DTR mouse shows that all the 
MNPs within the gut lamina propria are depleted in this model.46 
The migration of MNPs, to and within lymphoid tissues, is regu-
lated by the expression of various chemokines. However, the dis-
semination of TSE agents from the intestine to the GALT is not 
dependent on cell migration through the chemokine/receptor 
system CCL19/CCL21/CCR7.66
Figure 3. Depletion of DCs and macrophages in the spleen of the 
CD11c-DTr mouse. (B and D) CD11c+ DCs are partially depleted in this 
transgenic mouse line through the injection of Diphtheria toxin. CD169+ 
macrophages in the spleen are also depleted through their low level 
expression of CD11c. (A and C) Normal expression of CD11c and CD169 
in control mice. (C and D) are higher magnification images of (A and B).
Figure 4. Detection of LCs and langerin+ dermal DCs in the mouse ear following 
immunofluorescent labeling of epidermal and dermal sheets. (A) LCs form a dense 
network of cells within the epidermis. (B) Langerin+ dermal DCs are not abundant 
within the dermis as the LCs in the epidermis. A small number of these cells may also 
be migrating LCs.© 2012 Landes Bioscience.
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which raises the question whether 
skin-derived MNPs also play a role in 
the uptake and transport of the TSE 
agent from the skin to the LRS.
Following scrapie infection via 
skin scarification in the mouse, 
agent infectivity and PrPSc accumu-
lation occurs first in the skin drain-
ing LN soon after exposure.67,69,80 
Experimental scrapie transmission 
in sheep via the skin failed to find 
a conclusive link between DCs and 
the transport of PrPSc.81 However, 
neutrophils were found to associate 
with PrPSc. The definite involvement 
of skin resident MNPs in TSE agent 
transmission from the skin remains 
to be determined. Early research 
in mice also implied the lack of LC 
involvement.69,82 However, the use of 
transgenic mouse models that allow 
for the temporary depletion of LCs, 
DCs or macrophages55,83 prior to 
scrapie infection will help determine 
whether these cells play a role in TSE 
transmission from the skin as suggested after oral exposure. Any 
research looking into the role of skin DCs or macrophages in 
the dermis (Figs. 4 and 5). Classical DCs have been suggested 
to transport viruses such as HIV78 or Dengue79 from the skin, 
Figure 5. Schematic representation of the MNPs in the skin of the mouse. LCs can be found in the epidermis. The dermis is situated below the epider-
mis and comprises langerin+ as well as langerin- DCs and various macrophage populations. All these cell types migrate from the skin to the draining 
LN, and therefore may play a potential role in the transport of the TSe agent from the skin to the draining LN, where PrPSc accumulates following infec-
tion via the skin.
Figure 6. Schematic representation of the role of subcapsullar sinus macrophages in the transport 
of immune complexes to FDC in the LN. (1) Subcapsullar sinus macrophages capture lymph borne 
immune complexes in the subcapsullar sinus which they transcytose intact across their surfaces to 
underlying follicular B cells. (2) Non-cognate B cells acquire the immune complexes via their comple-
ment receptors and (3) deliver them to FDCs. (4) Cognate (antigen-specific) B cells, in contrast, acquire 
antigen-containing immune complexes via their B-cell receptors, become activated and (5) migrate to 
the boundary of the T-cell zone.© 2012 Landes Bioscience.
Do not distribute.
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studies in FDC-deficient RAG-/- mice, where scrapie disease was 
successfully transmitted.93 The discrepancies between these two 
studies may possibly be due to much higher levels of innervation 
in the RAG-/- mouse spleens when compared with those from 
TNFR1-/- mice.92
Following replication within lymphoid tissues, TSE agents 
are considered to spread to the brain via peripheral sympathetic 
nerves.94 However, it is plausible that due to their migratory 
nature, classical DCs carry TSE agents into the CNS across the 
blood-brain-barrier. Whether the immigration of TSE agent-
contaminated classical DCs or circulatory monocytes into the 
CNS plays an important role in neuroinvasion is uncertain, as 
significant monocytic infiltration into the brain during TSE dis-
ease has not been reported. In sheep infected with scrapie, PrPd 
accumulation within specific structures in the brain, the circum-
ventricular organs, was an early and consistent feature.95 These 
sites have fenestrated capillaries, and as such are sites of molecular 
exchange between the CNS and the blood-stream. However, the 
lack of monocytic cells within these organs throughout TSE dis-
ease is consistent with the hypothesis that cell-associated hema-
togenous spread is not a major route of neuroinvasion.
Macrophages: Saints or Sinners?
Macrophages. Macrophages typically phagocytose and degrade 
protein antigens more rapidly than classical DCs,96,97 which can 
retain some protein antigens in their native form up to 36 h after 
exposure.98 Data from in vitro studies likewise suggest that mac-
rophages also phagocytose and degrade TSE agents including 
scrapie and BSE.99-101 Furthermore, the depletion of macrophages 
before scrapie infection increased the accumulation of the scra-
pie agent in the spleen and accelerated disease pathogenesis.102 
Within the macrophage, PrPSc was also found to colocalize with 
lysosomal and proteasomal proteins,103 implying that, consistent 
with their biological characteristics, macrophages might play a 
preventative role in TSE disease when compared with classical 
DCs. However, data also imply that macrophages might trans-
port orally acquired TSE agents within the GALT.104 Whether 
the cells described are macrophages or classical DCs is uncer-
tain. As highlighted earlier, it is difficult to classify these cells by 
immunohistochemistry based on the expression of cell surface 
markers alone.
Tingible body macrophages. Tingible body macrophages are 
found in close association with FDCs within the germinal cen-
ters of follicles within lymphoid tissues, where they clear pro-
teins and apoptotic lymphocytes (tingible bodies).105 Data from 
ultrastructural studies show high levels of PrPSc within tingible 
body macrophages in lymphoid tissues of scrapie-affected mice 
and sheep.106-108 Deposition of PrPd within tingible body macro-
phages in lymphoid tissues of patients with vCJD have also been 
described in reference 109. Recent data suggests tingible body 
macrophages scavenge and degrade PrPSc following synthesis on 
other infected cells such as FDCs.45
Microglia. Microglia are the macrophages of the CNS. 
Gliosis, involving astrocytes and microglia, is one of the neuro-
pathological characteristics of terminal TSE disease. Microglia 
TSE transmission needs to be put into context with the LC para-
digm. Substantial heterogeneity has been revealed between MNP 
subtypes in different inbred mouse stains.84 For example, LC 
density in the epidermis is much lower in C57BL/6 mice when 
compared with BALB/c, 129/Sv and CBA mice. Such differences 
could significantly contribute to the differing results observed in 
many host species exposed to TSE agents.
In 2007, an important novel cell type was identified in the 
mouse dermis: the langerin+ dermal DC (Fig. 4).85-87 All der-
mal DCs were thought to be negative for langerin expression, a 
marker previously considered to be exclusive to LCs. These lan-
gerin+ dermal DCs have a much higher turnover rate than LCs 
and repopulate the skin several weeks faster than the epidermal 
LCs following depletion.83,88,89 Upon activation, for example by 
skin immunization, these langerin+ dermal DCs migrate from 
the skin to the draining LNs much earlier than the LCs.83 Thus, 
earlier studies addressing the role of LCs would not have been 
able to factor in the presence of this novel cell type which may 
have often skewed the interpretation of data in previous studies 
of LC immunobiology.
Since the identification of langerin+ dermal DCs, a number of 
publications have questioned the role of LCs in skin immunity, 
in particular the suggestion that they are the only APCs of the 
skin. Indeed, langerin+ dermal DCs have been shown to be fully 
capable of cross-presenting antigens regardless of whether LCs 
are present or not.90 Experiments where LC migration from the 
epidermis was blocked, in CD40L-/- mice or via caspase-1 inhibi-
tion, were previously used to determine whether LCs played a role 
in the transport of the scrapie agent from the skin to the draining 
LNs.69 While the early accumulation of TSE agent infectivity was 
not affected in the draining LNs, the incubation period of disease 
was significantly shortened in the CD40L-/- mice. These data 
implied that instead of aiding pathogenesis by transporting TSE 
agents from the skin, LCs may impede pathogenesis by phagocy-
tosing and degrading them.69,82 In light of recent findings, further 
experiments are necessary to distinguish the influence of LCs and 
langerin+ dermal DC in this process.
Classical DCs as Mediators of Neuroinvasion
As well as being involved in the transport of the TSE agent from 
the periphery to the LRS, classical DCs may have a role in the 
act of neuroinvasion within the lymphoid tissues, for example, 
the transport of TSE agents to peripheral nerves. Studies show 
evidence of the intercellular transport of PrPSc through tun-
nelling nanotubules from DCs to cultured neuronal cells.91 In 
some TSE diseases where there appears to be little or no LRS 
involvement (such as BSE in cattle, or sheep of certain PRNP 
genotypes infected with scrapie) neuroinvasion occurs by an 
unidentified process. Whether classical DCs fulfil this role as 
implied in the Gousset study91 is uncertain. However, studies 
performed in scrapie infected, FDC-deficient, TNFR1-/- mice, 
determined that MNPs were unlikely to have directly infected 
peripheral nerves within lymphoid tissues, as these mice failed 
to develop disease when injected with scrapie-infected CD11c+ 
cells (classical DCs).92 These results were in contrast to previous © 2012 Landes Bioscience.
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subcapsular sinus macrophages in LNs (and their counterparts in 
the spleen) play a key role in the delivery of complement-bound 
immune complexes to FDCs raises the possibility that these cells 
might also play an important role in the transport of comple-
ment-opsonized TSE agents to FDCs within lymphoid tissues. 
Indeed, disease-specific PrP has been detected within the subcap-
sular sinus macrophages of intestinally-exposed sheep.124
Concluding Remarks
This review aimed to highlight the potential involvement of the 
various MNP populations in TSE pathogenesis. Current data 
suggest MNPs may exhibit a diverse range of roles in TSE disease 
from the transport or destruction of TSE agents in lymphoid tis-
sues, to mediators or protectors of neuropathology in the brain. 
Much of the research described above studies the influence of 
MNPs on TSE pathogenesis during steady-state conditions. 
However, under inflammatory conditions MNPs may exacerbate 
TSE pathogenesis, for example through the release of neurotoxic 
mediators in the brain117 or the transmission of disease between 
individuals through the contamination of bodily secretions such 
as milk.125 While some MNPs may play important roles in TSE 
pathogenesis, it is equally likely that in some circumstances their 
involvement is minimal. The route of TSE infection, strain of 
TSE agent and host species may all influence the role of MNPs in 
disease pathogenesis. Indeed, it is equally probable that in some 
instances TSE agents reach the draining lymphoid tissues via a 
cell-free mechanism such as in a complement-bound immune 
complex or via the conduit system.123 Recent advances in immu-
nology have identified a long list of new members of the MNP 
phagocyte system, which may also have an important impact on 
TSE pathogenesis. Continuing research with the new tools and 
models available will help to unravel the mysteries that still sur-
round TSE pathogenesis.
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are the main source of the inflammatory response that is asso-
ciated with TSE disease, and microglial activation is directly 
linked to the patterns of PrPSc deposition in the brain, and pre-
cedes neuronal cell death.110,111 Significant vacuolar degeneration 
has been detected in the microglia/macrophages of two vCJD 
patients.112 Microglia and astrocytes have been associated with 
granular PrPd deposits, leading speculation that these cells play a 
role in processing, degrading or removing PrPSc.113 The in vitro 
exposure of microglia to murine scrapie brain homogenate or 
PrP(106–126) severely affected their phagocytic activity.114 In con-
trast, microglia from ME7-scrapie affected mice were capable of 
phagocytosis, but were not able to clear PrPSc.115 Within TSE-
affected brains the pro-inflammatory activity of microglia is spe-
cifically modulated by the anti-inflammatory cytokine TGFβ1. 
This cytokine appears to play a critical role in the downregula-
tion of pro-inflammatory microglial responses minimizing brain 
inflammation and thus avoiding exacerbation of brain damage.116 
Whether systemic infections and inflammation lead to the dis-
regulation of this control and the exacerbation of neurodegenera-
tion remains to be determined.117
A recently identified brain DC population, morphologically 
similar to microglia is considered to be a new member of the 
heterogeneous microglia population.118 However, it is uncertain 
whether these cells are a unique subset of classical DCs. These 
data indicate that, as in the other tissues discussed in this review, 
there are a number of different MNP populations that could 
influence TSE pathogenesis in the brain, depending on the cir-
cumstances. Furthermore, some data might relate to a particular 
subset of cells, rather than to the entirety of MNPs within the 
brain.
Subcapsular sinus macrophages. Subcapsular sinus macro-
phages are a distinct, poorly endocytic and degradative macro-
phage subset.119 These unique cells capture antigen-containing 
immune complexes arriving in the LN via their cell processes 
that they extend into the lumen of the subcapsular sinus.119-123 In 
contrast to other macrophage subsets, subcapsular sinus macro-
phages retain immune complexes on their surfaces for rapid trans-
location through the floor of the subcapsular sinus to underlying, 
non-cognate (non-specific) follicular B cells.119 These B cells then 
acquire the immune complexes via their complement receptors 
and deliver them to FDCs. The higher immune complex-binding 
affinities of FDCs most likely relieve the B cells of their cargo. 
Thus, the subcapsular sinus macrophage-B cell immune com-
plex relay represents an efficient route through which antigens 
are delivered to FDCs119-123 (Fig. 6). The demonstration that 
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